Critical 23S rRNA interactions for macrolide-dependent ribosome stalling on the ErmCL nascent peptide chain by Koch, Miriam et al.
Nucleic Acids Research, 2017 1
doi: 10.1093/nar/gkx195
Critical 23S rRNA interactions for
macrolide-dependent ribosome stalling on the ErmCL
nascent peptide chain
Miriam Koch1, Jessica Willi1, Ugo Prade`re2, Jonathan Hall2 and Norbert Polacek1,*
1Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland and
2Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, 8093 Zurich,
Switzerland
Received December 22, 2016; Revised March 09, 2017; Editorial Decision March 11, 2017; Accepted March 14, 2017
ABSTRACT
The nascent peptide exit tunnel has recently
been identified as a functional region of ribo-
somes contributing to translation regulation and co-
translational protein folding. Inducible expression
of the erm resistance genes depends on ribosome
stalling at specific codons of an upstream open read-
ing frame in the presence of an exit tunnel-bound
macrolide antibiotic. The molecular basis for this
translation arrest is still not fully understood. Here,
we used a nucleotide analog interference approach
to unravel important functional groups on 23S rRNA
residues in the ribosomal exit tunnel for ribosome
stalling on the ErmC leader peptide. By replacing
single nucleobase functional groups or even single
atoms we were able to demonstrate the importance
of A2062, A2503 and U2586 for drug-dependent ri-
bosome stalling. Our data show that the universally
conserved A2062 and A2503 are capable of forming a
non-Watson–Crick base pair that is critical for sens-
ing and transmitting the stalling signal from the exit
tunnel back to the peptidyl transferase center of the
ribosome. The nucleobases of A2062, A2503 as well
as U2586 do not contribute significantly to the over-
all mechanism of protein biosynthesis, yet their elab-
orate role for co-translational monitoring of nascent
peptide chains inside the exit tunnel can explain their
evolutionary conservation.
INTRODUCTION
The ribosome is a gigantic macromolecular machine trans-
lating the information encoded on a messenger RNA
(mRNA) into a polypeptide sequence by the sequential ad-
dition of single amino acids. Peptide bond formation is cat-
alyzed in the peptidyl transferase center (PTC), which is lo-
cated in a cleft on the intersubunit side of the large riboso-
mal subunit (1–3). In order to leave the ribosome and en-
ter into the cytosol, a newly synthesized polypeptide chain
passes through the ribosomal exit tunnel. This tunnel has a
diameter of 10–20 A˚ and a length of ∼100 A˚ and spans the
whole large ribosomal subunit. The ribosomal exit tunnel is
mainly composed of ribosomal RNA (rRNA), as shown by
X-ray structures of the bacterial and archaeal ribosomes (4–
7). The functional role and contribution of the ribosomal
exit tunnel to polypeptide synthesis and protein folding is
only beginning to be understood in molecular terms. In re-
cent years, it became evident that the tunnel plays an active
role in translation regulation and protein folding (reviewed
in 8–10). Translation regulation is achieved by specific in-
teractions of the nascent polypeptides with the tunnel wall,
resulting in the extreme cases in a programmed translation
arrest, the so-called ribosomal stalling.
Ribosomal stalling has been described for several bacte-
rial (e.g. ermC, ermA, ermB, secM, mifM, tnaC), eukaryal
(e.g. the arginine attenuator peptide AAP) as well as for vi-
ral (upstream open reading frame of a cytomegalovirus gly-
coprotein) genes (reviewed in 11). Typically, programmed
ribosome stalling in the upstream open reading frame
(uORF) is utilized to regulate translation of a downstream
ORF. In bacteria programmed translational arrest in the
upstream ORF (uORF) results in an upregulation of ex-
pression of the downstream gene. This either occurs via
transcriptional anti-termination when the stalled ribosome
blocks the binding site of the Rho transcription termina-
tor or via inducing a conformation rearrangement in the
mRNA structure, thereby exposing the Shine-Dalgarno se-
quence of the downstreamORF, allowing ribosome binding
and therefore translation (11).
One well-characterized and important class of genes reg-
ulated by programmed translational arrest are the erm genes
that encode rRNA methyltransferase enzymes conferring
resistance to erythromycin and other macrolide antibiotics
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(12). The ermC gene is one member of this class and its
expression is controlled by an uORF encoding the leader
peptide ErmCL (13,14). In the absence of macrolide antibi-
otics, the ribosome binding site and start codon of ermC
are sequestered in a stem loop structure and are there-
fore inaccessible for initiating ribosomes (Figure 1A). How-
ever, in the presence of sub-inhibitory concentrations of the
macrolide, the ribosome stalls with the isoleucine codon at
position 9 (Ile9) of ermCL in the P-site. Ribosome stalling
induces rearrangements of the mRNA structure thus ex-
posing the ribosome binding site of the downstream ORF
allowing the ErmC methyltransferase encoded in ermC to
be expressed (12). Insights into the molecular mechanism
of macrolide-induced ribosome stalling upon synthesis of
the ErmC leader peptide have been gained in genetic (14),
biochemical (15–17) and structural studies (18). It has been
shown that the four C-terminal ErmCL residues I6F7V8I9
are crucial for ribosome stalling and that translation is ar-
rested likely due to the PTC adopting an inactive confor-
mation that prevents peptide bond formation with the in-
coming Ser-tRNASer at the 10th ermCL codon position
(17). It has been shown that mutations of the universally
conserved 23S rRNA nucleotide A2062 and A2503 (Es-
cherichia coli nomenclature here and throughout) abolish
stalling on the ermCL ORF, highlighting a crucial role of
these tunnel residues (16). It has been suggested that these
two adenosines come into hydrogen bonding distance in
the presence of the stalling peptide sequence forming a
non-Watson-Crick base pair (3,16,18,19). Notably, muta-
tions of A2062 or A2503 show strictly parallel effect on
translation arrest (mutations of both diminish stalling on
ermCL, ermAL1 and secM, whereas they do not affect
stalling on ermBL, ermDL and tnaC), suggesting that both
adeninesmay act as components of the same signaling path-
way from the tunnel to the PTC (16). Besides these two
rRNA residues, the recent cryo-EM structure of the ermCL
stalled ribosomal complex revealed other 23S rRNA tun-
nel residues to interact with the ErmCL nascent chain or
to adopt a distinct conformation in the stalled ribosome
suggesting a possible contribution to translation arrest (18).
One of these residues is U2506, which interacts with V8 of
the ErmCL nascent polypeptide chain and seems to stack
upon the aromatic side chain of F7. Both V8 and F7 belong
to the ErmCL amino acids (I6F7V8I9) crucial for stalling
(17). The same might be true for U2586 that interacts with
I6 of the ErmCL nascent chain. Mutation of U2586 to ei-
ther A, C or G did not affect wildtype ermCL stalling,
whereas the arrest efficiency of ermCL-I6A could be par-
tially rescued by these mutations (18). Furthermore, the
structure also revealed an interaction of the ErmCL criti-
cal I6F7V8I9 sequence with A2062 thus supporting a steric
role of the N-terminus for ribosome stalling (17).
To gain molecular insight into the contribution and
specific interactions of distinct 23S rRNA residues to
macrolide-induced ribosome stalling upon synthesis of
ErmCL,we are using the atomicmutagenesis approach (20–
22). This experimental approach allows the introduction of
non-natural nucleoside analogs into the 23S rRNA in the
context of functional 70S ribosomes. By this technique sin-
gle functional group or even single atom substitutions of
23S rRNA residues are possible. To identify the 23S rRNA
functional groups and interactions that are involved in sens-
ing the arrest peptide and possibly transmitting the signal
to the PTC, we targeted the ‘main suspects’ for ErmCL
stalling, namely A2062, U2503, U2506, U2585, U2586 and
A2602 by this nucleotide analogue interference approach.
MATERIALS AND METHODS
Reconstitution of 50S subunits
Generation of the circularly permuted (cp) 23S rRNA, sub-
sequent in vitro reconstitution of the 50S particles from
Thermus aquaticus, and reassociation with native E. coli
30S ribosomal subunits were performed as previously de-
scribed (20,21,23). Reconstitution reactions contained ei-
ther 0.5 mM low molecular weight facilitators of the in
vitro 50S subunit assembly: either RU66252 (stalling) or
solithromycin (translation). The presence of macrolide an-
tibiotics positively affect in vitro assembly of 50S subunits
(24). After reconstitution and association with native 30S
E. coli subunits, the ribosomal particles are ethanol pre-
cipitated and subsequently resuspended directly in the re-
spective reaction buffer (see below). This precipitation step
significantly reduces the macrolide concentration initially
needed for efficient 50S reconstitution, since no inhibi-
tion of downstream functional assays has been observed
(20,25,26). Since solithromycin does not trigger ermCL
stalling (17), whereas RU66252 does, we used the former
for 50S reconstitutions employed in subsequent translation
control reactions, and the latter for all stalling experiments
(see below). Primers used for generation of the different
DNA templates for the cp-23S rRNA in vitro transcription
are listed in Supplementary Table S1. Cp-23S rRNA con-
structs are named the following way: first number marks
the 5′-end of the cp-23S rRNA and the second number in-
dicates the 3′-end (Supplementary Figure S1). During in
vitro reconstitution of the 50S ribosomal subunit the intro-
duced sequence gap in the cp-23S rRNA encompassing the
23S rRNA residue under investigation, was compensated
by chemically synthesized RNA oligonucleotide, contain-
ing either the unmodified wild-type sequences or carrying
a single nucleoside analog (Supplementary Table S1). Olig-
oribonucleotides were added in 5-fold molar excess over cp-
23S rRNA during 50S in vitro reconstitution (20).
Synthetic RNA oligonucleotides
Non-modified RNA strands as well as those containing
a ribose-abasic site analog or the 2-pyridone modifica-
tion were purchased from Microsynth. All other oligori-
bonucleotides were synthesized via standard solid-phase
synthesis using 2′-O-TBDMS phosphoramidites on a 50
nmol scale (27).The dimethylamino group of oligoribonu-
cleotides 2585 DMA-Py and 2586 DMA-Py was intro-
duced using the convertible nucleoside approach as de-
scribed previously (28,29). For deprotection and cleavage
from solid support, samples were treated with 40% aq.
dimethylamine for 2.5 h at 40◦C. An equal volume of 25%
aq. ammonia was then added and temperature was raised
to 65◦C for 30 min. RNA was desilylated using 1-methyl-2-
pyrrolidone (NMP), triethylamine (TEA), and TEA.3HF
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Figure 1. The macrolide-inducible ermC gene and the 23S rRNA residues investigated for their role in translation arrest. (A) Structure of the regulatory
region of the inducible ermC gene in the non-induced (upper panel) and induced (lower panel) conformation. The exit tunnel-bound macrolide antibiotic
in the large 50S subunit is depicted as purple hexagon and the nascent peptide chain is in green. Amino acid sequence of ErmC leader peptide (ErmCL)
and the N-terminus of the ErmC are depicted above the corresponding codons. Shine Dalgarno sequence, start and stop codons are shown in red. (B) 3D
representation of the PTC and tunnel residues in the ErmCL stalled ribosomal complex (18) (based on the structure pdb 3J7Z) that have been modified and
tested for their impact on ribosomal stalling. The PTC residue A2451, whose ribose 2′-OH group is pivotal for peptide bond formation (23,40), is shown
as well to indicate the catalytic heart of the active site. The sugar-phosphate backbone of the P-site located peptidyl-tRNA and the density for I6F7V8I9
of ErmCL are depicted in dark and light grey, respectively. Amino acids for which sufficient density was observed in the SRC are labeled in grey. (C) The
listed nucleoside analogs were introduced via the atomic mutagenesis approach into the PTC or the exit tunnel of the 50S ribosomal subunit and their
activities were tested in macrolide-dependent ribosome stalling.
(6:3:4) for 90 min at 70◦C. Reaction was quenched us-
ing Ethoxytrimethylsilane and samples were purified via
HPLC (Agilent 1200 Series; Agilent Technologies) on a
C18 column (XBridge OST, particle size 2.5m; Waters).
Oligoribonucleotides 2503-Purine, 2503-7-deaza-rA, 2062-
7-deaza-rA and 2062-Purine were synthesized as above and
deprotected in a single stepwith gaseousmethylamine. Olig-
oribonucleotides were analyzed and confirmed by mass
spectrometry (2585 DMA-Py: Masscalc = 9419.8, Massobs
= 9419.2; 2586 DMA-Py: Masscalc = 9420.8, Massobs
= 9420.2; 2503-Purine: Masscalc = 12491.5, Massobs =
12491.4; 2503-7-deaza-rA: Masscalc = 12505.5, Massobs =
12504.2; 2062-7-deaza-rA: Masscalc = 8362.1, Massobs =
8361.4; 2062-Purine: Masscalc = 8348.1, Massobs = 8348.5).
Toeprint assay
The DNA template for in vitro transcription/translation of
ermCLwas amplified via PCR from the pUC18-ermCLT10-
tandem using 5′-TAATACGACTCACTATAGGG-3′ as
forward and 5′-GAACTCATTGTCACTGGTTC-3′ as re-
verse primer, respectively. The ermCLT10-tandem plasmid
was generated by cloning the 2xermCL construct (18) into
the pUC18 vector via blunt ligation into the SmaI site.
The ermBL DNA template was generated by PCR using
two long overlapping primers. For detection of stalled ri-
bosome complexes by toe-printing, 2 pmol of reconsti-
tuted and ethanol precipitated 70S ribosomes were used
per in vitro translation reaction. In vitro translation was
performed using the Δ ribosomes PURE system (NEB
E3312S). The final reaction volume was 5 l. In vitro
transcription/translation reactions contained 2 l solution
A, 0.6 l factor mix, 1 pmol of 5′ 32P-labeled primer
(toe-tandem-1: 5′-GAACTCATTGTCACTGGTTC-3′), 8
u RNase inhibitor (ThermoFisher Scientific) and 10 ng of
DNA template. The ethanol precipitated reconstituted ribo-
somes were resuspended in the above translation mixture.
The macrolide RU66252 was added to a final concentra-
tion of 50 M, whereas translation control reactions con-
tained 50 M mupirocin (Ile-tRNA-Synthetase Inhibitor,
Sigma Aldrich). All components were combined and the re-
action was started by placing the tubes at 37◦C. The sam-
ples were incubated for 30 min. For cDNA synthesis 1 l of
reverse transcription mixture containing 2 u/l AMV-RT
(Roche, diluted with PSB (9 mMMg(OAc)2, 5 mMK3PO4
pH 7.3, 95 mM potassium glutamate, 5 mM NH4Cl, 0.5
mM CaCl2, 1 mM spermidine, 8 mM putrescine, 1 mM
DTT)) and 2mMdNTPswere added. Reverse transcription
was performed for 10 min at 37◦C. Reactions were stopped
by addition of 1 l 10 N NaOH and incubation followed
for additional 10 min at 37◦C. NaOH was neutralized by
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the addition of 0.8 l HCl (37% (v/v)). Prior to phenol–
chloroform–isoamylalcohol (PCI) extraction, 200 l of re-
suspension buffer (0.3 M NaOAc pH 5.5, 5 mM EDTA pH
8.0, 0.5% (w/v) SDS) were added to the reactions. After PCI
extraction samples were precipitated by the addition of 600
l ethanol (100% (v/v)) in the presence of 0.5 l glycoblue
(ThermoFisher Scientific) for 30 min at –80◦C. After cen-
trifugation (30 min at 18 000 × g, 4◦C) pellets were washed
with 70% (v/v) ethanol, air-dried and resuspended in 8 l
of loading dye (98% formamide, 5 mMEDTA pH 8.0, 0.1%
(w/v) bromphenol blue, 0.1% (w/v) xylene cyanol). Sam-
ples were heated up for 1 min at 95◦C prior loading on a 6%
denaturing 7M Urea polyacrylamide gel (40 cm × 20 cm ×
0.375 mm). The gel was run in 1× TBE at 2,000 V, 40W for
1–1.5 h. The gel was dried on a vacuum dryer for 45 min at
70◦C and exposed overnight to a phosphoimager screen.
In vitro translation of ribosomal protein L12 mRNA
In vitro translation of ribosomal protein L12 mRNA using
in vitro reconstituted ribosomes in the presence of 35S me-
thionine was performed as previously described (20). The
radiolabeled reaction products were separated on SDSpoly-
acrylamide gels and detected by phosphorimaging.
Macrolide footprinting
50S reconstitution reactions with 10 pmol cp23S rRNA
(cp2596-2566) carrying the compensating synthetic RNA
oligonucleotide with either the wildtype or 2-pyridone at
position 2586 were set up without macrolides or in the
presence of 0.5 mM solithromycin or RU66252, respec-
tively. The chemically engineered 50S subunits were puri-
fied by passing them through a 20% sucrose cushion as de-
scribed (30) and the pellets were resuspended in 20 l buffer
(20 mM Hepes/KOH pH 7.6, 10 mM MgOAc2, 150 mM
NH4Cl, 4 mM 2-mercaptoethanol, 2 mM spermidine, 50
M spermine) containing 100 M of either solithromycin
or RU66252. Macrolides were allowed to bind to reconsti-
tuted 50S or native 50S subunits from T. aquaticus for 5 min
at 37◦C. Dimethylsulfate (1:6 in ethanol, Sigma Aldrich)
was added to a final concentration of 100 mM and probing
was performed at 37◦C for 15 min. Reactions were termi-
nated, rRNA purified and used for reverse transcription as
described previously (30,31). For reverse transcription the
5′-32P labeled DNA primer 5′-CATCCTACGCAGGCGC
GA-3′ was used and the reaction products were analyzed on
a 10% denaturing 7M urea polyacrylamide gel.
RESULTS
Ribosome stalling using in vitro reconstituted ribosomes
In order to investigate the role of distinct 23S rRNA
residues in macrolide-induced ribosomal stalling on the
molecular level, we use the atomic mutagenesis approach
(see Figure 1B for a representation of PTC and exit tun-
nel residues tested). This procedure is based on the in vitro
assembly of the 50S ribosomal subunit using components
from the thermophilic bacteria T. aquaticus (20,21,32).
We first established the experimental system by analyz-
ing if in vitro translation of the arrest peptide ErmCL
and macrolide-dependent ribosome stalling could be repro-
duced using native as well as in vitro reconstituted 50S sub-
units from T. aquaticus. We employed purified native 50S
subunits from T. aquaticus as well as reconstituted 50S con-
taining in vitro 23S rRNA transcripts in combination with
native E. coli 30S for ribosome stalling in presence of the
macrolide RU66252. In the presence of this macrolide na-
tive ribosomes stall at the ninth codon of ermCL with the
Ile9-tRNA in the P-site (Figure 1A). Such stalling events
can be detected using the inhibition of primer extension
(toeprint) as readout (17). Similar to the E. coli system,
ribosomes with T. aquaticus 50S subunits (native as well
as in vitro assembled) stall efficiently in the presence of
the macrolide antibiotic RU66252 as reflected by the spe-
cific toeprint band (Figure 2A,C). Importantly this toeprint
band only appears in the presence of RU66252 confirm-
ing a drug-specific translation arrest in the presence of this
macrolide antibiotic. We noticed an increased toeprinting
signal at the AUG start codon of ermCL in case of employ-
ing hybrid ribosomes consisting of native E. coli 30S sub-
units and native or reconstituted T. aquaticus 50S subunits
compared to experiments with E. coli 70S ribosomes (Sup-
plementary Figure S2A). This indicates reduced activity of
the hybrid ribosomes during the transition from the initia-
tion to the elongation phase of protein biosynthesis. In the
absence of any translation this start codon toeprint disap-
pears and solely a primer extension stop around the stop
codon remains which is indicative of an mRNA secondary
structure-dependent reverse transcriptase stop (Supplemen-
tary Figure S2B).
A2602 in the PTC is not required for drug dependent transla-
tion arrest
To investigate the role of the highly flexible 23S rRNA nu-
cleotide A2602, which was found in a distinct conforma-
tion in the ErmCL stalled ribosomal complex (SRC) com-
pared to empty ribosomes (18), we in vitro reconstituted ri-
bosomes lacking this nucleotide. A2602 is universally con-
served, bulges out of 23S rRNA helix 93 (Supplementary
Figure S1) and could potentially contribute to ribosome
stalling based on its conformational flexibility. Ribosomes
lacking A2602 have been shown before to be fully active
in in vitro translation (25), however are defective in release
factor-mediated peptidyl-tRNAhydrolysis (33,34). In order
to confirm the translational activity of reconstituted ribo-
somes in the toeprint assay, mupirocin, an inhibitor of Ile-
tRNA-synthetase, was added. The presence of mupirocin
leads to the depletion of Ile-tRNAIle in the translation re-
action resulting in an accumulation of ribosomal complexes
with an Ile codon in the A-site. The corresponding transla-
tion arrest is reflected by the toeprint bands at codon posi-
tions 3 and 6 (Figure 2B), thereby confirming the capability
of the mutant in vitro reconstituted ribosomes for translat-
ing the ermCL template. In the presence of RU66252, ri-
bosomes lacking A2602 could nevertheless efficiently stall
with the lle9-peptidyl tRNA in the P-site (Figure 2B). These
results thus demonstrate that A2602 is not involved in the
macrolide-dependent programmed translational arrest at
the ermCL gene. We noticed increased primer extension
stops around the stop codon when using ribosomes lacking
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Figure 2. In vitro reconstituted ribosomes efficiently stall in the presence of a macrolide on ermCL. (A) Comparison of native hybrid ribosomes (30S E.coli
and 50S T.aq.) with in vitro reconstituted ribosomes carrying the 23S rRNA wild type (wt) T7 transcript. In vitro translation of ErmCL was carried out
in the presence or absence of the macrolide RU66252 as indicated. Ribosomal stalling was analyzed by the toeprint assay. Reactions were analyzed on
a sequencing gel along with dideoxy-sequencing reactions (C, U, A, G). The sequence of ermCL is shown along with the sequencing gel and the site of
toeprint is indicated by arrows. The isoleucine 9 codon, positioned in the P-site of the stalled ribosome, is boxed. The primer extension stops corresponding
to ribosomes occupying the AUG start codon and to the location of the stop codon are indicated by filled arrowheads. The locations of the radiolabeled
primer as well as the full length reverse transcription product are highlighted as well. (B) Toeprint assay comparing reconstituted ribosomes carrying the
wt 23S rRNA in vitro transcript to ribosomes harboring a 23S rRNA with deleted residue A2602 (2602). In vitro translation was performed either in the
presence of RU66252 ormupirocin (Mup).Mupirocin inhibits Ile-tRNA synthetase, leading to accumulation of ribosomes with an emptyA-Site (Ile codon)
and was used as translation control. In the presence of mupirocin ribosomes arrest translation at Il3 or Ile6 in the A-site, respectively (open arrowheads).
Filled arrowheads mark the position of the start codon toeprint and the location of the stop codon, respectively. Reverse transcription analyses of two
independent stalling experiments are shown. In total this particular stalling experiment was repeated 6 times. See Supplementary Figure S3 for uncropped
gels. (C) The chemical structures of the semi-synthetic macrolides RU66252 and solithromycin (both used in this study) and erythromycin, from which they
derive. Solithromycin lacks the C3 cladinose sugar and thus is not active in ermCL stalling (17). RU66252 does carry a C3 cladinose and has in addition
an extended alkyl-aryl side chain attached at the C11 and C12 atoms. These features of RU66252 turned out to be superior for ermCL stalling compared
to erythromycin in this experimental system.
nucleotide A2602 (Figure 2B), which is in line with previ-
ous results demonstrating compromised termination rates
of ribosomes lacking this adenosine (33–35).
Sensing of the translation arrest signal involves A2062
The highly conserved A2062 is located in the upper part of
the nascent peptide exit tunnel and is one of the most flexi-
ble 23S rRNA nucleotides in this region of the large riboso-
mal subunit (36). Mutation of this residue has been shown
to abolish ribosomal stalling on ermCL (16). In the cryo-
EM structure of the SRC A2062 is found in a distinct con-
formation, folded flat against the exit tunnel wall and poten-
tially forming a hydrogen bonding interaction with A2503
(Figure 3A) (18). Here, we used the atomic mutagenesis ap-
proach to introduce specific modifications either at A2062
or A2503 that disrupt the suggested hydrogen bonding in-
teractions between these two residues (16,18). In order to
incorporate modified bases at position A2062, we used a
circularly permuted (cp) 23S rRNA containing a short se-
quence gap around this position. The sequence gap in the
23S rRNA was complemented during in vitro reconstitu-
tion by a synthetic RNA oligonucleotide carrying either
the wild-type (wt) sequence or a nucleoside analog at posi-
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Figure 3. Interaction of A2062 with A2503 is crucial for induced ribosomal arrest on ermCL. (A) Two possible interactions of 23S rRNA residues A2062
and A2503 based on the structure of the ErmCL stalled ribosomal complex (pdb 3J7Z) (18). The exocyclic C6 amino group of A2062 might form a
hydrogen bond with N7 of A2503 (possible interaction I). Alternatively, N7 of A2062 might interact via hydrogen bonding with the C6 exocyclic amino
group of A2503 (possible interaction II). (B) Toeprint analysis of in vitro reconstituted ribosomes, carrying different modifications at position A2062,
either in the presence of RU66252 (RU) or in the presence of mupirocin (Mup). Toeprint bands resulting from macrolide induced translational arrest are
highlighted by arrows, bands originating from depletion of aminoacylated Ile-tRNAIle by open arrowheads. Filled arrowheads mark the position of the
start codon toeprint and the location of the stop codon, respectively. This particular stalling experiment was repeated 4–7 times. aba: abasic site analog,
C7A: 7-deaza-adenosine, Pu: purine nucleobase analog. (C) Toeprinting analysis with ribosomes carrying nucleoside modifications at position 2503. All
abbreviations as in (B). This particular stalling experiment was repeated 4–10 times. (D) Ribosomes containing non-natural nucleoside analogs at positions
2062 or 2503 were used in a toeprint assay to detect ribosomal stalling on ermBL. Stalling on ermBL occurs with the asparagine codon at position 10 in the
P-site. Toeprint bands are indicated by solid arrows. This particular stalling experiment was repeated twice. See Supplementary Figure S4 for uncropped
gels.
tion 2062 (see Supplementary Figure S1 for all cp23S rRNA
constructs used). When we removed the whole 2062 nucle-
obase by introduction of an abasic site, the ribosomes were
still actively translating as shown by the mupirocin control
and the toeprint bands at Ile 3 and 6 (Figure 3B). Ribo-
somes with an abasic site at A2062 were furthermore fully
active in translating a control full-length protein, namely ri-
bosomal protein L12 (Figure 4). However, removal of the
nucleobase rendered ribosomes inactive in specific transla-
tion arrest at Ile9 in the presence of the macrolide. To test
more specifically the suggested interaction with A2503 and
the relay pathway (Figure 3A), we either replaced the N7 of
the nucleobase of A2062 with a carbon by the introduction
of a 7-deaza-adenosine (C7A) or removed its C6 exocyclic
amino group, by placing a purine at position 2062 (Figure
1C). Bothmodifications did not affect general in vitro trans-
lation activity of these ribosomes as shown in the mupirocin
control (Figure 3B). However, removal of the C6 exocyclic
amino group by placing the purine nucleoside analog drasti-
cally interfered with ribosomal stalling on ermCL, whereas
removing the H-bond acceptor at the N7 position by in-
troducing 7-deaza-adenosine showed no effect (Figure 3B).
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Figure 4. In vitro translation activity of ribosomes composed of reconstituted 50S subunits and native E. coli 30S subunits. In all cases the mRNA coding
for ribosomal protein L12 fromMethanococcus thermolithotrophicuswas used and the [35S]-labeled translation products were detected by exposing the SDS
gels to phosphorimager screens (20). The reconstituted 50S either contained full length 23S rRNA in vitro transcripts (23S Taq), a cp-23S rRNA without
compensating synthetic RNA oligo (w/o), or cp-23S rRNA with RNA oligos encoding the wild type sequence (wt) or harboring nucleoside modifications
(see Figure 1C for details). As positive control native E. coli 70S ribosomes were used. The faint L12 products sometimes seen in the negative control
reactions without compensating RNA oligos (w/o) originate from minor 50S contaminations of the 30S subunit preparation. Note that for unknown
reasons in the reaction shown in the lowest panel, multiple translation product bands appeared. These bands likely represent truncated L12 r-proteins that
are nevertheless translation products of the chemically engineered ribosomes.
From this we conclude that the functional group of A2062,
crucial for sensing and likely signaling of the translation ar-
rest, is the exocyclic NH2-group at position C6 of the ade-
nine nucleobase.
Interaction of A2062 with A2503 is crucial for ribosome
stalling on ermCL
In order to further characterize the suggested interaction
between A2062 and A2503, we introduced the reciprocal
nucleobase modifications at A2503 in order to test possible
hydrogen bonding contacts. Ribosomes carrying a purine at
position 2503, and thus lacking the hydrogen bond donor
functionality of the C6 exocyclic group of the nucleobase,
were actively translating as demonstrated in the mupirocin
and L12 mRNA translation controls (Figures 3C and 4).
Importantly, ribosomes with a purine at 23S rRNAposition
2503 still efficiently stall in the presence of the macrolide
upon synthesis of ErmCL (Figure 3C). In contrast, when
the 7-deaza-adenosine nucleoside analog was introduced
at position 2503, drug-dependent translation arrest was
strongly impaired, even though these ribosomes were still
capable of actively synthesizing proteins (Figures 3C and
4). These data show that the N7 of A2503 is involved in
an interaction that is important for establishing the trans-
lation arrest. Therefore, the obtained atomic mutagenesis
data are compatible with the view that the crucial interac-
tion between 23S rRNA residues 2062 and 2503 takes place
between the N7 of A2503 and the NH2-group at position
C6 of A2062 (Figure 3A; possible interaction I).
The A2062-A2503 interaction is not involved in stalling on
ermBL
After having shown the crucial roles of specific functional
groups at A2503 and A2062 for ribosomal stalling on
ermCL, we next investigated the specificity of these findings.
Therefore, we tested ribosomes carrying a purine at 2062 or
a C7A at 2503 for their ability to arrest translation upon
synthesis of another stalling peptide, ErmBL. It has been
shown before that stalling sequences can be arranged into
groups according to their dependency on residues A2062
and A2503 for translation arrest (16). The first group in-
cludes ErmCL, ErmAL1 and SecM that strictly depend on
these two adenine residues. However, themutations at either
A2062 or A2503 did not abolish stalling at ermBL, ermDL
and tnaC regulatory genes (16). In support of these previous
data, ribosomes modified at position 2503 (C7A) or 2062
(purine), modifications that abolished stalling on ermCL,
efficiently arrested translation on ermBL in the presence
of the macrolide RU66252 (Figure 3D). This highlights
the highly specific roles of A2503 and A2062 for ErmCL
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stalling. Furthermore, these findings also demonstrate that
the abolished stalling for ribosomes with 2503 C7A or 2062
purine modifications during ermCL translation is not the
result of diminished macrolide binding. These findings sug-
gest that different relay pathways operate for recognizing
ErmCL and ErmBL stalling peptides and transmitting the
stalling signal from the ribosomal exit tunnel to the PTC.
U2506 contributes to ribosome stalling
In the cryo-EM structure of the ErmCL SRC, density for a
putative interaction has been observed of U2506 with F7
and V8 of ErmCL. The nucleobase of U2506 stacks on
F7, whereas the C4 carbonyl might interact with V8. As
F7 and V8 are part of the essential I6F7V8I9 stalling mo-
tif of ErmCL this observed interaction might be important,
but its functionality has yet to be biochemically validated.
Therefore, to investigate the possible role of the F7/F8 in-
teraction with U2506 on stalling, we first removed the en-
tire nucleobase at position 2506, which resulted in abol-
ished stalling, whereas translation activity was only mildly
affected (Figures 5A and 4). In order to understand this in-
teraction in more detail, we removed the carbonyl group at
the C4 position of uracil (and concomitantly the N3) by in-
troducing a 2-pyridone analog (Figure 1C). This ablation is
expected to disrupt the U2506–V8 interaction. Unexpect-
edly, ribosomes carrying a 2-pyridone at position 2506 lost
the capability for in vitro translation (Figure 4). This is the
first nucleobase modification of an active site residue that
completely abolished translation activities (1,20). Due to
this lack of activity we could not further evaluate the role
of the C4 carbonyl group for ribosome stalling. Our data
nevertheless highlight the importance of the proposed in-
teraction of the 2506 nucleobase with amino acids F7 and
V8 of ErmCL for macrolide dependent ribosome stalling.
2585 and 2586
In E. coli the highly conserved U2585 and U2586 have
been connected with translation arrest. The structure of the
ErmCL SRC showed U2585 in a very distinct conforma-
tion, as it is flipped out by 80◦ compared to the unaccom-
modated state (18). Importantly the C4 carbonyl oxygen of
U2585 is in hydrogen bonding distance to the A76 ribose 2′
OH-group of the A-site tRNA during binding and accom-
modation. In the flipped out conformation of U2585 ob-
served in the ErmCL-stalled complex this interaction can-
not be established, which led to the proposal that reorien-
tation of U2585 accounts for the weak A-site tRNA bind-
ing for the ErmCL SRC (18). In order to evaluate the role
of U2585 in translation arrest on ErmCL we first removed
the entire nucleobase. Translational activity of these mod-
ified ribosomes was somewhat decreased (Figure 4), how-
ever these ribosomes were still able to stall on ermCL (Fig-
ure 5B). To analyze the contribution of U2585 more closely
we eliminated its C4 carbonyl oxygen (and simultaneously
also replaced the N3 with a carbon) by incorporation of
a 2-pyridone (Figure 1C). Translational activity of these
ribosomes was slightly impaired (Figure 4), however they
retained their ability to arrest translation, albeit less effi-
ciently compared to the wt construct (Figure 5B). The re-
duced activity in the stalling assay is therefore attributed to
the decreased overall translational activity. However, when
we instead replaced the C4 carbonyl with a dimethyl-amino
group (Figure 1C), the picture changed. Despite the resid-
ual translation activity of these ribosomes (Figure 4), we
could not detect any stalling on ermCL in the presence of
the macrolide RU66252 (Figure 5B). The fact that removal
of the whole nucleobase still allows stalling, whereas the
4-dimethyl-amino-pyrimidine does not, might be explained
by the bulkiness of the two additional methyl groups at C4
of the pyrimidine nucleobase analog which likely interferes
sterically with the stalling reaction. From these data we con-
clude that nucleobase modification at U2585 primarily de-
creases translation activity, probably because in all modifi-
cations the C4 carbonyl oxygen is lacking and therefore the
proposed interaction with the A76 ribose 2′ OH-group of
the A-tRNA cannot be established. Besides these defects in
overall translation, nucleobase modifications of U2585 (ex-
cept 4-dimethyl-amino-pyrimidine) did not interfere with
translation arrest on ermCL. It follows that U2585 plays
an important role in translational activities, however, it is
not particularly critical for macrolide-dependent ribosomal
stalling on ermCL.
A different picture emerged whenwe introduced the same
set of modifications as described above at position 2586.
While E. coli carries a uracil at this position, T. aquaticus
ribosomes have C2586. Based on the cryo-EM structure of
the ErmCL SRC,U2586 has been suggested to interact with
the crucial Ile6 of ErmCL (18). Ribosomes carrying an aba-
sic site at 2586 were only slightly hampered in their abil-
ity to synthesize proteins. Ribosomes carrying either a 2-
pyridone or a 4-dimethyl-amino-pyrimidine at 2586 showed
translational activity comparable to the wt control (Fig-
ure 4). Despite being active in translation, ribosomes har-
boring modified nucleoside analogs at 2586 failed to stall
on ermCL in the presence of the macrolide antibiotic (Fig-
ure 5B). This suggests that the crucial interaction from 23S
rRNA residue 2586 with the ErmCL nascent peptide chain
is executed likely via the C4 exocyclic group (or alternatively
via its N3). To validate that C2586 base modifications do
not affect macrolide binding, and thus would affect ermCL
stalling indirectly, we performed RU66252 footprinting ex-
periments with reconstituted T. aquaticus 50S subunits. It
turned out that the characteristic macrolide footprints at
23S rRNA positions A2058/A2059 (37) were unaffected by
the introduced base modifications at C2586 (Figure 5C).
These data demonstrate that the failure of ribosomes car-
rying base modifications at 2586 to stall at the ermCLORF
is not the consequence of diminished macrolide antibiotic
binding. Altogether, our results suggest that the nucleobase
of U2585 is required for proper translation activity but is
dispensable for translation arrest on ermCL. On the other
hand, the nucleobase of 2586 does not impact much over-
all translation, while its C4 exocyclic group is essential for
induced ribosomal stalling.
DISCUSSION
In order to specifically arrest translation upon synthe-
sis of the ErmC leader peptide (ErmCL) in a macrolide-
dependent manner, specific interactions of nascent chain
residues with 23S rRNA tunnel nucleotides are required.
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Figure 5. Role of the rRNA residues 2506, 2585 and 2586 in ribosomal stalling on ermCL. (A) Toeprint analysis using in vitro reconstituted ribosomes
to characterize the contribution of U2506. In vitro translation has been performed in the presence of RU66252 (RU) to analyze their ability to stall at the
ninth codon position in the P-site. Reactions in the presence of mupirocin (Mup) served as translation controls. Toeprint bands resulting from macrolide-
induced translational arrest are highlighted by arrows, while bands originating fromdepletion of aminoacylated Ile-tRNAare shownwith open arrowheads.
Filled arrowheads mark the position of the start codon toeprint and the location of the stop codon, respectively. This particular stalling experiment was
repeated six times. (B) Ribosomes carrying different modifications either at position 2585 or 2586 were used in the toeprint assay to monitor effects on
ribosomal stalling in the presence of RU66252 (RU). In vitro reconstituted 50S subunits carrying no compensating synthetic RNA oligonucleotide (w/o)
or the unmodified synthetic RNA fragment (wt) served as negative and positive stalling controls, respectively. This particular stalling experiment was
repeated four times. Abbreviations used: aba: abasic site analog, Pyr: 2-pyridone, DMA-Py: 4-dimethylamino-pyrimidine. See Supplementary Figure S5
for uncropped gels. (C) The DMS reactivities of residues A2058/A2059 in the absence (–) or presence of the macrolides solithromycin (Sol) or RU66252
(RU) was used to monitor binding efficiencies of the antibiotics to native 50S particles (left gel) or reconstituted 50S subunits (right gel). Other DMS
reactive residues that do not change modification efficiencies upon macrolide binding and that are similar in native as well as reconstituted 50 S subunits
are highlighted as well. G, C, U, A denote dideoxy sequencing reactions. Note that the reverse transcriptase always stops one nucleotide 3′ of the actually
methylated nucleobase.
Putatively crucial interactions have been identified by the
cryo-EM structure of the ErmCL SRC and by mutational
analysis of 23S rRNA nucleotides in the exit tunnel (16,18).
Here, we applied the atomic mutagenesis approach (20)
to unravel functionally critical 23S rRNA residues in the
nascent peptide exit tunnel and in the PTC for macrolide-
dependent ribosome stalling. This nucleotide analogue in-
terference method allows studying the functional conse-
quences of single functional group replacements of 23S
rRNA nucleosides in the context of in vitro assembled 70S
ribosomes. Beside obvious advantages of this experimen-
tal approach, it is known that the overall reconstitution ef-
ficiency is rather low and the obtained ribosomes possess
reduced reaction kinetics (23). Therefore we primarily in-
terpreted the apparent stalling efficiencies on a qualitative
rather than quantitative level. To compensate for these lim-
itations of the experimental system we always compared re-
sults obtained with ribosomes originating from the same set
of parallel 50S subunit reconstitutions and repeated each
stalling experiment multiple times (see the corresponding
figure legends for details). Our study revealed that in vitro
reconstituted ribosomes are indeed capable of programmed
10 Nucleic Acids Research, 2017
translational arrest which is a clearly more demanding ac-
tivity compared to forging single peptide bonds (21), ac-
tivating translational GTPases (22,38), or translating ho-
mopolymeric mRNA analogs (25,30). In order to function
during macrolide-dependent ribosome stalling the reconsti-
tuted and chemically modified ribosomes not only need to
be active in translation of a heteropolymeric mRNA, but
also need to sense the stalling signal of the nascent peptide
and the antibiotic molecule within the exit tunnel and trans-
mit it back to the PTC (Figures 1A and 2A). In line with
our previous observations (25,30), most of the introduced
modifications at the different 23S rRNA positions did not
interfere with overall translation activity. Importantly not
all introduced 23S rRNAmodifications on PTC or exit tun-
nel residues abolished stalling on ermCL. For example com-
plete deletion of the universally conserved A2602 or abla-
tion of the nucleobase at U2585 did not eliminate the ribo-
some’s ability to respond to the presence of macrolides by
arresting translation of the ermCL ORF (Figures 2B and
5B). These findings highlight the principle applicability of
chemically engineered ribosomes generated by atomic mu-
tagenesis to functionally pinpoint crucial 23S rRNA groups
for drug-dependent ribosome stalling.
Our data unravel important roles for two adenine nucle-
obases at positions 2503 and 2062 in the nascent peptide exit
tunnel for ribosome stalling. In particular the N7 nitrogen
atA2503 and theC6 exocyclic amino group atA2062 turned
out to be crucial for ErmCL-dependent translation arrest
(Figure 3). While replacement of a single heteroatom (the
N7 nitrogen by a carbon) or the ablation of the C6 amino
group at A2503 and A2062, respectively, did not eliminate
overall protein synthesis (Figure 4), it completely destroyed
the macrolide-dependent ribosome stalling potential on the
ermCL ORF (Figure 3B). The findings of unaffected ac-
tivities in protein biosynthesis, as revealed by the in vitro
translation data (Figure 4) and the mupirocin controls (Fig-
ure 3B and C), make potential peptidyl-tRNA drop-off as
the cause for the lack of ribosome stalling unlikely. Im-
portantly, the very same nucleobase groups at A2503 and
A2062 are not critical for stalling on the ErmBL nascent
chain (Figure 3D). This demonstrates that these chemically
engineered ribosomes retain their general activity for sens-
ing the nascent peptide inside the exit tunnel, and points
to amino acid specific roles of A2503 and A2062 during the
ErmCL-mediated arrest. Based on these findings we suggest
that in order to establish a precise translation arrest within
the ermCL ORF, the N7 of A2503 interacts with the C6
exocyclic amino-group of A2062 likely via hydrogen bond-
ing (Figure 3A; possible interaction I). This interpretation
is compatible with genetic data showing that the adenines at
2503 and 2062 are critically involved in translational arrest
on ermCL (16). Also recent structural data emphasize a cru-
cial role of these nucleotides since it has been suggested that
the N-terminus of ErmCL forces the otherwise highly flexi-
ble A2062 in a distinct conformation flat against the tunnel
wall (18). Only in this constrained conformation, the spe-
cific interaction with A2503 can be established.
While the roles of the nascent peptide chain, certain
rRNA residues in the tunnel wall and a ribosome-bound
macrolide in programmed translation arrest at ermCL has
been largely established, themeans by which the stalling sig-
nal is transmitted from the tunnel to the PTC is still unclear.
Basically there are two options: either the signal is transmit-
ted via the nascent polypeptide chain (18) or via 23S rRNA
residues (17). Our data are fully compatible with the latter
scenario since A2062 is flanked by G2061 and C2063. Both
of these nucleosides belong to the outer shell of the PTC and
participate in positioning ofA2451, the key catalytic residue
in the active site (4,35,39,40). Therefore A2062 seems to be
perfectly located to sense the nascent polypeptide chain and
communicate the stalling signal to the PTC. The crucial role
of A2503 and A2062 for signal transmission was also em-
phasized by molecular dynamics simulations (41). A2062 is
universally conserved and highly flexible (42). Importantly,
also the mobility of this residue seems to be highly con-
served suggesting that the ribosome requires this flexibility
for its proper functioning. Unexpectedly, complete elimina-
tion of the entire nucleobase at 2062 had essentially no ef-
fect on in vitro protein synthesis (Figure 4 and ref. 25) in-
dicating a more elaborate role of the adenine base. Indeed,
here we show that the highly flexible A2062 is required for
fine-tuning protein synthesis, namely for sensing the reg-
ulatory nascent peptide chain for macrolide-induced ribo-
somal stalling upon synthesis of ErmCL. The crucial co-
player ofA2062 in ribosomal stalling is the highly conserved
A2503. A2503 is one of the few postranscriptionally mod-
ified rRNA residue in E. coli and other bacteria carrying a
C2methyl group. It has been shown that posttranscriptional
modification of A2503 affects the ability of the ribosome to
stall upon synthesis of ErmCL (16). However, in our exper-
imental system, which depends on in vitro transcripts of 23S
rRNA, A2503 is unmodified, yet the ribosomes are still ca-
pable of establishing the canonical stalling complex (Figure
2A).
Besides A2503/A2062 other residues were also identi-
fied to contribute to ribosome stalling. U2585 and U2586
contact the nascent ErmCL in the exit tunnel (18). All of
the nucleobase modifications tested at U2585 markedly re-
duced the ribosomes ability to translate heteroploymeric
mRNA (Figure 4), whereas they were fully active in the
puromycin reaction and in poly(U) translation (23,25). Im-
portantly, none of the introduced nucleobase modifications
at U2585 possess a C4 carbonyl oxygen or a group with sim-
ilar chemical properties (Figure 1C). This might lead to an
impaired A-site tRNA accommodation efficiency as sug-
gested by others (18,43–45). Significantly, even though we
observed a clear decrease in translation activity when re-
placing the uridine at 2585 by an abasic site analog or by
the 2-pyridone nucleoside, those ribosomes were still able
to stall at the expected site on the ermCL ORF (Figure
5B). These data indicate that the nucleobase at U2585 con-
tributes to overall translation activity, however is not re-
quired for ribosomal stalling. In clear contrast to these find-
ings are the results obtained for nucleobase modifications at
the neighboring position 2586. Although translation activ-
ity was slightly decreased, we could still observe substantial
translation products (Figure 4). However, all of the nucle-
obase modifications introduced at 2586 severely interfered
with ribosomal stalling on ermCL, emphasizing the impor-
tance of this residue for translation arrest. These results are
supported by structural data, showing U2586 in close prox-
imity to Ile6 of the ErmCL nascent peptide (18). Ile6 is one
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of the amino acids that are crucial for ermCL stalling as its
mutation to alanine completely abolishes stalling (17). In-
terestingly, mutation of U2586 (to either A, C or G) does
not eradicate stalling, but can partially restore stalling of
the I6A-ErmCL mutant (18). In these standard mutagene-
sis experiments (18), all 2586 mutants retained a C4 or C6
exocyclic group with free electron pairs and thus hydrogen
bond acceptor capabilities. However in our atomic mutage-
nesis approach we completely removed or significantly dis-
turbed this hydrogen bond acceptor functionality by remov-
ing either the entire nucleobase, or by the ablation of the C4
exocyclic group, or by placing a bulky C4 dimethylamino
group. Our observations are compatible with two scenar-
ios: (i) the exocyclic C4 group at position 2586 is needed to
form a crucial interaction with Ile6 of the ErmCL (possibly
via hydrogen bonding), or (ii) it is required to expand the
aromatic -electron system thus enhancing stacking inter-
actions with Ile6.
In summary, our experiments corroborate and expand
previous conclusions suggesting crucial roles for the 23S
rRNA residues A2062, A2503 and U2586 (E. coli nomen-
clature) for translation arrest on ermCL, but not on ermBL.
By utilizing the power of the atomic mutagenesis approach
we could unravel important molecular interactions for ri-
bosome stalling in more detail. The results on A2062 and
A2503 strongly suggest that the interaction between these
two nucleobases is established via the C6 exocyclic amino
group of A2062 and the N7 of A2503. Those adenosines
are universally conserved, yet they do not contribute piv-
otally to overall translation. This indicates that their evolu-
tionary sequence constraint originates from functional roles
that go beyond mere protein biosynthesis. We believe that
the intra-ribosomal A2062/A2503-dependent signal trans-
mission activity might represent such an elaborate role for
these two 23S rRNA residues.
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